Shanghai Fudan Forward S&T Co., Ltd (SHA:600624)
China · Delayed Price · Currency is CNY 7.08
-0.03 (-0.42%)
Sep 12, 2025, 10:44 AM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Financial Insurance System Software | 196.38M | Log In | Log In | Log In | Log In | Upgrade |
Financial Insurance System Software Growth | 0.99% | Log In | Log In | Log In | Log In | Upgrade |
Digestive System Medicines | 141.42M | Log In | Log In | Log In | Log In | Upgrade |
Digestive System Medicines Growth | -20.36% | Log In | Log In | Log In | Log In | Upgrade |
Drugs for the Nervous System | 80.59M | Log In | Log In | Log In | Log In | Upgrade |
Drugs for the Nervous System Growth | -1.32% | Log In | Log In | Log In | Log In | Upgrade |
Other Medicines | 23.05M | Log In | Log In | Log In | Log In | Upgrade |
Other Medicines Growth | -6.50% | Log In | Log In | Log In | Log In | Upgrade |
Circulatory System Drugs | 21.10M | Log In | Log In | Log In | Log In | Upgrade |
Circulatory System Drugs Growth | -31.22% | Log In | Log In | Log In | Log In | Upgrade |
Anti-tumor Drugs | 18.66M | Log In | Log In | Log In | Log In | Upgrade |
Anti-tumor Drugs Growth | 54.21% | Log In | Log In | Log In | Log In | Upgrade |
Immune Function Regulating Drugs | 15.71M | Log In | Log In | Log In | Log In | Upgrade |
Immune Function Regulating Drugs Growth | 2.17% | Log In | Log In | Log In | Log In | Upgrade |
Other Business | 12.67M | Log In | Log In | Log In | Log In | Upgrade |
Other Business Growth | -2.39% | Log In | Log In | Log In | Log In | Upgrade |
Fuhua Park Haimen Garden Supporting Residential Project (Fuhua Wenyuan) | 2.93M | Log In | Log In | Log In | Log In | Upgrade |
Fuhua Park Haimen Garden Supporting Residential Project (Fuhua Wenyuan) Growth | 33.19% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
China | 372.54M | Log In | Log In | Log In | Log In | Upgrade |
China Growth | -10.58% | Log In | Log In | Log In | Log In | Upgrade |
Overseas | 272.78M | Log In | Log In | Log In | Log In | Upgrade |
Overseas Growth | 3.69% | Log In | Log In | Log In | Log In | Upgrade |